Long-term remission with ustekinumab in a patient with PAPA syndrome suggests the importance of IL-12/IL-23 cytokines in PSTPIP1-associated inflammatory diseases.

IF 10.9 1区医学 Q1 RHEUMATOLOGY

Arthritis & Rheumatology Pub Date : 2025-09-22 DOI:10.1002/art.43399

Nico Wittmann,Dominik Nell,Magdalena Mohs,Marie C Grude,Neha Mishra,Almut Meyer-Bahlburg,Lukas Bossaller

引用次数: 0

查看原文本刊更多论文

ustekinumab治疗PAPA综合征患者的长期缓解提示IL-12/IL-23细胞因子在pstpip1相关炎症性疾病中的重要性。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Arthritis & Rheumatology RHEUMATOLOGY-

CiteScore

20.90

自引率

3.00%

发文量

371

期刊介绍： Arthritis & Rheumatology is the official journal of the American College of Rheumatology and focuses on the natural history, pathophysiology, treatment, and outcome of rheumatic diseases. It is a peer-reviewed publication that aims to provide the highest quality basic and clinical research in this field. The journal covers a wide range of investigative areas and also includes review articles, editorials, and educational material for researchers and clinicians. Being recognized as a leading research journal in rheumatology, Arthritis & Rheumatology serves the global community of rheumatology investigators and clinicians.